Demand for topical pain relief will increase through 2036, with opioids at 18.0% of the drug class segment in 2026. The market was valued at USD 11.7 billion in 2025 and is expected to be worth USD 21.31 billion by 2036, creating an incremental opportunity of USD 8.95 billion.